Notifications
The metastatic prostate cancer market is witnessing robust growth, driven by advancements in precision medicine and targeted therapies such as PSMA-targeted radioligand therapy and immune checkpoint inhibitors. Genomic profiling-guided personalized treatment plans are increasing effectiveness and re...
What is metastatic prostate cancer? Metastatic prostate cancer refers to prostate cancer that has spread from the prostate gland to other parts of the body, most commonly the bones, lymph nodes, liver, or lungs. This stage of cancer, also known as stage IV, is more advanced and often harder to treat...
